Investigation of the Anti-Inflammatory and Analgesic Activities of Ethanol Extract of Stem Bark of Sonapatha<i> Oroxylum indicum In Vivo</i>

Lalrinzuali, K.; Vabeiryureilai, M.; Jagetia, Ganesh Chandra

doi:https://doi.org/10.1155/2016/8247014

International Journal of Inflammation

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2016 | Article ID 8247014 | https://doi.org/10.1155/2016/8247014

Investigation of the Anti-Inflammatory and Analgesic Activities of Ethanol Extract of Stem Bark of Sonapatha Oroxylum indicum In Vivo

K. Lalrinzuali,¹M. Vabeiryureilai,¹and Ganesh Chandra Jagetia¹

Academic Editor: Kamyar Kalantar-Zadeh

Received16 Oct 2015

Revised17 Dec 2015

Accepted29 Dec 2015

Published26 Jan 2016

Abstract

Inflammation is all a pervasive phenomenon, which is elicited by the body in response to obnoxious stimuli as a protective measure. However, sustained inflammation leads to several diseases including cancer. Therefore it is necessary to neutralize inflammation. Sonapatha (Oroxylum indicum), a medicinal plant, is traditionally used as a medicine in Ayurveda and other folk systems of medicine. It is commonly used to treat inflammatory diseases including rheumatoid arthritis and asthma. Despite this fact its anti-inflammatory and analgesic effects are not evaluated scientifically. Therefore, the anti-inflammatory and analgesic activities of Sonapatha (Oroxylum indicum) were studied in Swiss albino mice by different methods. The hot plate, acetic acid, and tail immersion tests were used to evaluate the analgesic activity whereas xylene-induced ear edema and formalin induced paw edema tests were used to study the anti-inflammatory activity of Sonapatha. The administration of mice with 250 and 300 mg/kg b.wt. of O. indicum reduced pain and inflammation indicating that Sonapatha possesses analgesic and anti-inflammatory activities. The maximum analgesic and anti-inflammatory activities were observed in mice receiving 300 mg/kg b.wt. of O. indicum ethanol extract. Our study indicates that O. indicum possesses both anti-inflammatory and analgesic activities and it may be useful as an anti-inflammatory agent in the inflammation related disorders.

1. Introduction

The inflammation is a sequence of events that occurs in response to noxious stimuli, infection, trauma, or injury in the living tissues [1]. The inflammation is initiated by a cascade of events including enzyme activation, mediator release, fluid extravasations, cell migration, tissue breakdown, and repair processes [2]. The inflammation releases white blood cells as a protective measure against injury. These white blood cells synthesize several biomolecules and release them after injury leading to swelling and redness. The inflammation is characterized by induction of pain, redness, and rashes [3]. Prostaglandins are one of the important biomolecules, which play a key role in the induction of inflammatory response as their biosynthesis is significantly increased during inflammation [4]. The inflammatory responses are elicited as a defense mechanism by an organism or tissues; however, sustained inflammation can lead to undesired health effect as a consequence of interplay of various biomolecules that are secreted during the process of inflammation. Inflammation has been indicated in several diseases including cancer [5, 6]. The agents that contain or block inflammation may play an important role in treating pathologies associated with inflammatory reactions [7].

Natural products have a long history of use as a folk remedy for inflammatory conditions including fevers, pain, migraine, and arthritis. Many of the diseases in the modern world are thought to be due to inflammation; therefore, anti-inflammatory agents, anti-inflammatory food and food products are of great interest to contain or reduce inflammation-induced health disorders [8]. Fossil records indicate the use of natural products, especially the plants as medicine since Middle Paleolithic (approximately 60,000 years) age [9]. The modern allopathic drugs are single active chemical molecules and target one specific pathway, whereas herbal medicines contain pleiotropic molecules that work on an orchestral approach which are able to target many elements of the complex cellular pathway [10]. The pain and inflammatory conditions are usually managed by either steroidal (corticosteroids) or nonsteroidal (aspirin) drugs, which induce toxic side effects at different levels including allergic reactions, occasional hearing loss, and renal failure. These drugs also increase the risk of hemorrhage by negatively altering platelet function [11]. The medicinal plants have been a major source of a wide variety of biologically active compounds for many centuries and have been used extensively in crude form or as pure isolated compounds to treat various disease conditions including inflammation [12].

The inflammatory conditions can be cured using plant or plant derived products effectively. Clerodendron inerme has been reported to exhibit anti-inflammatory activity in vitro [13]. Hydrocotyle umbellata and several other plants have been reported to possess anti-inflammatory activity in different study systems [14, 15]. Sonapatha or Oroxylum indicum belongs to Family Bignoniaceae and it is characterized by brown bark and large pinnate leaves. It is a medium sized, deciduous tree, distributed in India, Sri Lanka, Malaysia, China, Thailand, Philippines, and Indonesia. In India, Oroxylum is found in Eastern and Western Ghats and also in the North-East regions [16]. The existence of Oroxylum indicum (L) Vent. in natural population is highly threatened and it has been categorized as endangered medicinal plant by the Government of India. Various parts of Oroxylum indicum are utilized for medicinal purposes [17]. It has been used in Ayurveda and other traditional medicinal health systems since centuries [18]. The decoction of the bark is used to cure gastric ulcers and the bark paste is useful in treating mouth cancer, scabies, and other skin diseases. The bark paste is applied to the wounds of animals to kill maggots. Poultice of the bark is topically applied to treat rheumatism, sprains, inflammations, and skin diseases [19]. The bark decoction of Oroxylum is also a useful remedy to deworm cattle [20]. Apart from this, Oroxylum species are reported to have a variety of medicinal properties like anticancer, antiulcer, antidysenteric, antimicrobial, and anti-inflammatory [21]. It has been shown to be antibacterial, antioxidant, hepatoprotective, and immunomodulatory [22]. From the above it is clear that the systematic evaluation of anti-inflammatory and analgesic activities of Oroxylum indicum is lacking, which stimulated us to obtain an insight into the anti-inflammatory and analgesic activities of Oroxylum indicum in Swiss albino mice.

2. Materials and Methods

2.1. Preparation of Extract

The noninfected and matured stem bark of Oroxylum indicum (Family: Bignoniaceae) was collected from Champhai (23.456°N latitude and 93.329°E longitude), Mizoram, India, during the month of January. The plant was identified by the Department of Horticulture and Aromatic and Medicinal Plants, Mizoram University, Aizawl, India. The bark of O. indicum was thoroughly rinsed with clean water and shade dried at room temperature in the dark in clean and hygienic conditions. The dried bark was powdered in an electrical grinder at room temperature. The stem bark powder of O. indicum was sequentially extracted in petroleum ether, chloroform, ethanol, and distilled water according to increase in polarity using a Soxhlet apparatus until the solvents became colourless [23]. The ethanol extract was concentrated using rotary evaporator and stored at −70°C until further use. Henceforth the ethanol extract of O. indicum will be referred to as OIE throughout the paper.

2.2. Animal Care and Handling

The animal care and handling were carried out according to the guidelines issued by the World Health Organization, Geneva, Switzerland, and the INSA (Indian National Science Academy, New Delhi, India). Usually, 6-to-8-week-old healthy male Swiss albino mice weighing 30–35 g were selected from an inbred colony maintained under the controlled conditions of temperature () and humidity (55–60%) with 12 hours of light and dark cycle, respectively. The animals were housed in a sterile polypropylene cage containing paddy husk (procured locally) as bedding material. The animals had free access to standard rodent diet and water. All animal experiments were carried out according to NIH and Indian National Science Academy, New Delhi, India guidelines. The study was approved by the Institutional Animal Ethics Committee of the Mizoram University, Aizawl, Mizoram: India vide letter number MZU/IAEC/4503.

2.3. Experimental

The anti-inflammatory and analgesic activities were determined by dividing the animals into the following groups.

2.3.1. SPS Group

The animals of this group did not receive any treatment except the sterile physiological saline (SPS).

2.3.2. DIF Group

The animals of this group were injected with 20 mg/kg b.wt. of diclofenac sodium intraperitoneally.

2.3.3. OIE Group

The animals of this group were administered with 250 and 300 mg/kg b.wt. of ethanol extract of Oroxylum indicum intraperitoneally.

The analgesic and anti-inflammatory activities were determined 30 minutes after the administration of SPS or diclofenac (DIF) or ethanol extract of Oroxylum indicum.

2.4. Analgesic Activity

The analgesic activity of OIE was determined by carrying out the following tests.

2.4.1. Hot Plate Test

A separate experiment was conducted to determine analgesic activity of OIE by the hot plate test as described earlier [24], where the grouping and other conditions were essentially similar to those described above. The hotplate contained metallic surface (diameter 20 and 10 cm high) and its temperature was set at 55°C. Briefly, each mouse was placed onto the hotplate and covered with a glass beaker to avoid heat loss. Each mouse also acted as its own control. The time taken to lick the fore paws or jumping was recorded. The latency is defined as the reaction time taken by each mouse to respond to licking of the fore paws or jumping. Untreated animals exhibiting latency of 5–20 s were selected. The latency period for all groups was recorded thirty minutes after administration. Usually 10 mice were used for each group.

The percent inhibition was calculated as follows:

2.4.2. Acetic Acid Induced Writhing Test

A separate experiment was performed to evaluate the analgesic activity by acetic acid induced writhing test, which was carried out as described earlier [25]. The grouping and other conditions were essentially similar to those described earlier. The mice were administered intraperitoneally with 0.7% v/v acetic acid (volume of acetic acid did not exceed 10 μL/g b.wt.). Immediately after acetic acid administration, the mice were individually placed into glass beakers and five min was allowed to elapse. The number of writhes produced in these animals was counted up to 30 min. For scoring purposes, a writhe is indicated by stretching of the abdomen with simultaneous stretching of at least one hind limb. Usually 10 mice were used for each group.

Inhibition of writhing (%) was calculated as follows:

2.4.3. Tail Immersion Test

A separate experiment was conducted to evaluate the analgesic activity of Sonapatha ethanol extract by tail immersion test according to the procedure described elsewhere [26]. The grouping and other conditions were essentially similar to those described above in Section 2.3. The tail immersion test was carried out in a hot water bath set at a temperature of , where 3 cm of animal tail was immersed into the hot water and tail withdrawal reaction was recorded as time in seconds in all groups using a digital stopwatch. A minimum of two observations were collected for each animal in control group, immediately and 10 min after the initial reading. The tail withdrawal test was carried out in the treatment groups periodically at 0, 0.5, 1, 2, 3, 4, and 6 hours after administration of OIE, or diclofenac. Usually 10 mice were used for each group.

2.5. Anti-Inflammatory Activity

The anti-inflammatory activity was studied by xylene-induced ear edema and formalin induced paw edema in mice.

2.5.1. Xylene-Induced Ear Edema

A separate experiment was carried out to evaluate the anti-inflammatory activity by xylene-induced ear edema as described earlier [27]. The grouping and other conditions were essentially similar to those described above in Section 2.3. Mice were divided into five groups of 10 animals each. The mice were intraperitoneally administered with either distilled water (10 μL/g b.wt.) or diclofenac (20 mg/kg b.wt.) or OIE (250–300 mg/kg b.wt.). Thirty minutes after administration the inner surface of right ear of each animal was applied with 0.03 mL of xylene for the induction of ear edema, whereas the left ear served as the control. Fifteen minutes after the application of xylene, the mice were killed under ketamine anesthesia. Circular sections of both the ears were taken, using a cork borer of 6 mm, and weighed:

2.5.2. Formalin Induced Inflammation

A separate experiment was conducted to evaluate the anti-inflammatory activity by formalin induced inflammation. The grouping and other conditions were essentially similar to those described above in Section 2.3. The anti-inflammatory activity was assessed as described earlier [28]. Swiss albino mice were divided into groups of ten. The inflammation was produced by subaponeurotic injection of 0.1 mL of 2% formaldehyde in the right hind paw of the mice on the first and third day. The animals were treated daily with the OIE and diclofenac intraperitoneally for 10 days. The daily changes in paw size were measured by wrapping a piece of cotton thread around the paw and measuring the circumference with a meter rule. Usually 10 mice were used for each group.

2.6. Statistical Analysis

The data were analyzed by one-way ANOVA, followed by application of Tukey test (Pro 8 SRO v8.0724 (B724)), Northampton, MA, USA. A value of <0.05 was considered to be statistically significant.

3. Results

The results of analgesic and anti-inflammatory activities are presented in Tables 1–4 and Figure 1.

3.1. Analgesic Activity

3.1.1. Hot Plate Test

The analgesic activity was assessed using the hot plate method (Table 1). The administration of ethanol extract (OIE) showed a significant analgesic activity for both 250 and 300 mg/kg and 300 mg/kg exhibited the highest activity (62.5% inhibition) as compared to 250 mg/kg b.wt. (52.63% inhibition) as indicated by pain attenuation. The positive control diclofenac showed higher analgesic activity than OIE (76.31% inhibition) at a dose of 20 mg/kg b.wt. (Table 1).

3.1.2. Acetic Acid Induced Writhing Test

The results of acid writhing test are depicted in Table 2. Administration of acetic acid to control mice produced writhes within 30-minute observation period. Pretreatment with the OIE at 250 and 300 mg/kg b.wt. reduced the number of writhes up to (66.0% inhibition) and (68.58% inhibition), respectively. The standard drug diclofenac reduced the number of writhes to (83.68% inhibition) at a dose of 20 mg/kg b.wt. (Table 2).

3.1.3. Tail Immersion Test

Analgesic activity was also estimated using tail immersion test. The tail immersion test indicated that both the doses of the extract as well as the positive controls showed a significant inhibition in tail immersion rest when compared to the negative control (Table 3). The maximum analgesic effect was recorded for 300 mg/kg b.wt. OIE. The diclofenac (positive control) showed better activity as compared to the OIE.

3.2. Anti-Inflammatory Activity

3.2.1. Xylene-Induced Ear Edema

The results of the anti-inflammatory study using xylene-induced ear edema are shown in Table 4. SPS treated control mice showed an increase in ear weight up to mg and the OIE administration has inhibited this weight gain by 68.097% ( mg) and 71.3877% ( mg) for 250 and 300 mg/kg b.wt. of OIE, respectively (Table 4). The positive control diclofenac showed 52.72% ( mg) inhibition at 20 mg/kg b.wt. which was lower as compared to both the doses of OIE (Table 4).

3.2.2. Formalin Induced Inflammation

Treatment of mice with OIE gradually reduced diameters of the paw with time in both the treated and positive control groups (Figure 1). The OIE reduced the inflammatory reactions when compared to the SPS control group as indicated by the significant reduction in the paw diameter (Figure 1). However, the effect was more pronounced for 300 mg/kg OIE treatment (Figure 1).

4. Discussion

Inflammation is well orchestrated response to deleterious stimuli including tissue injury, and infection [29]. It is elicited to restore normal condition of tissue or body. Classically inflammation is characterized by increase in the blood flow, reddening of the affected part due to increased erythrocyte accumulation and edema [30]. Physiologically inflammation results in the secretion of numerous cytokines, acute phase proteins, and recruitment of leucocytes to the site of injury [29]. Inflammation has been indicated as a major cause in the development of several diseases in humans including neurological, cardiovascular, intestinal, dental, and renal disorders. Inflammation is also linked to ageing, diabetes, obesity, ankylosing spondylitis, multiple sclerosis, pancreatitis, and cancer [29, 31–36]. The strategies to combat inflammation will be useful in reducing the inflammation related disorders. Therefore, the present study was undertaken to evaluate the analgesic and anti-inflammatory activities of Oroxylum indicum in mice.

The analgesic activity of Oroxylum indicum was studied by the hot plate, tail immersion, and acetic acid tests, which are standard procedures to evaluate central and peripheral nervous system acting analgesics [37, 38]. The acetic acid is known to trigger the production of noxious substances within the peritoneum resulting in writhing response [37]. It is a simple, rapid, and reliable model and especially suitable to evaluate peripheral type of analgesic action of any drug [39]. The administration of Oroxylum indicum extract showed a significant analgesic activity indicating that it has some analgesic effect on both the central and peripheral nervous systems as indicated by reduced pain by hot plate method and suppression of acetic acid induced writhing. Several plant extracts including Adhatoda vasica, Acacia hydaspica, Boswellia serrate, Glaucium grandiflorum, and Landolphia owariensis have shown analgesic activity in vivo [40–44]. The tail immersion test has been used as a standard procedure to study the analgesic activity of pharmacological agents [45, 46], which was originally devised by [47]. The withdrawal latency is unusually determined once or twice to limit the conditioning effect [46]. The increase in the tail withdrawal latency is a good measure of analgesia induced by any chemical agent. Treatment of mice with Oroxylum indicum extract increased tail withdrawal latency confirming its analgesic effects.

The anti-acute inflammatory activity of any agent can be determined by xylene-induced ear edema or formalin induced paw edema tests [48, 49]. The formalin administration elicits behavioral effects stimulated by nociceptors. The inflammatory phase induced pain evokes a combination of stimuli, including inflammation of peripheral tissues and mechanisms of central sensitization [50, 51]. The central nervous system acting drugs including opioids suppress both phases equally; however drugs that act on peripheral nervous system such as NSAIDs and corticosteroids only inhibit the second phase [50]. Our findings indicate that Oroxylum indicum extract acts as anti-inflammatory agent as it reduced the xylene-induced ear edema as well as formalin induced paw edema in treated mice. Oroxylum indicum extract has been effective in both the central and peripheral nervous systems since it was able to desensitize neurons of both central and peripheral nervous systems equally as indicated by the attenuation of pain and inflammation. Many plants have been reported to possess anti-inflammatory activity in various study systems [15, 52]. Similarly, Adhatoda vasica, Acacia hydaspica, Boswellia serrate, Glaucium grandiflorum, and Landolphia owariensis, Harpagophytum procumbens, Rosa canina, Oenothera biennis, Ribes nigrum, Borago officinalis, Zingiber officinale, Nigella sativa, and Folium eriobotryae have been reported to act as anti-inflammatory agents in different study systems [40–44, 53, 54].

The exact mechanism of suppression of inflammation by O. indicum is not known. However, it contains flavonoids and other phenolic compounds that may have contributed to its analgesic and anti-inflammatory actions. O. indicum has been found to scavenge DPPH, superoxide anion, hydroxyl, nitric oxide, and Fe³⁺ radicals, which are major players in eliciting the inflammatory response [55]. Apart from free radical scavenging, it may have also reduced activation of cytokines like NF-κB, TNFα, IL-1β, and IFNγ. Inflammation has been reported to stimulate the activation of these cytokines [56, 57]. Biochanin-A present in the root bark of O. indicum has been reported to inhibit TNFα [58]. Chrysin has been isolated from the ethanol extract of O. indicum (data not shown) which has been reported to suppress the transcriptional activation of NF-κB and Cox-II [59]. The observed anti-inflammatory action of O. indicum may also be due to its inhibitory action on cyclooxygenase which is involved in prostaglandin synthesis [60].

5. Conclusions

Our study demonstrates that the O. indicum acts as an analgesic and anti-inflammatory agent. The analgesic and anti-inflammatory activities of O. indicum may be due to its ability to neutralize free radicals which are the main players in inflammation. It may have also suppressed the activation of proinflammatory cytokines including NF-κB, TNFα, IL-1β, and IFNγ and the activity of cyclooxygenase enzymes which are involved in inflammation. The anti-inflammatory and analgesic activities of O. indicum may be due to the presence of flavonoids and other polyphenols. The O. indicum may be used to reduce inflammation; however, further studies are required to understand molecular mechanisms of action against inflammation.

Conflict of Interests

The authors wish to confirm that there is no known conflict of interests associated with this paper and there has been no significant financial support for this work that could have influenced its outcome.

Acknowledgments

The authors are thankful to the University Grants Commission (UGC), New Delhi, India, Rajiv Gandhi National Fellowship–ST programme for providing financial assistance to Miss K. Lalrinzuali and the CSIR, Government of India, New Delhi Fellowship to Mr. M. Vabeiryureilai. The financial assistance from DBT and UGC Government of India, New Delhi, to Professor G. C. Jagetia is also thankfully acknowledged.

References

J. B. Calixto, M. M. Campos, M. F. Otuki, and A. R. S. Santos, “Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules,” Planta Medica, vol. 70, no. 2, pp. 93–103, 2004.
View at: Publisher Site | Google Scholar
W. E. Risso, I. S. Scarminio, and E. G. Moreira, “Antinociceptive and acute toxicity evaluation of Vernonia condensata Baker leaves extracted with different solvents and their mixtures,” Indian Journal of Experimental Biology, vol. 48, no. 8, pp. 811–816, 2010.
View at: Google Scholar
G. Opdenakker, W. E. Fibbe, and J. V. Damme, “The molecular basis of leukocytosis,” Immunology Today, vol. 19, no. 4, pp. 182–189, 1998.
View at: Publisher Site | Google Scholar
E. Ricciotti and G. A. FitzGerald, “Prostaglandins and inflammation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 5, pp. 986–1000, 2011.
View at: Publisher Site | Google Scholar
S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, inflammation, and cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010.
View at: Publisher Site | Google Scholar
M. M. Moore, W. Chua, K. A. Charles, and S. J. Clarke, “Inflammation and cancer: causes and consequences,” Clinical Pharmacology and Therapeutics, vol. 87, no. 4, pp. 504–508, 2010.
View at: Publisher Site | Google Scholar
S. Sosa, M. J. Balick, R. Arvigo et al., “Screening of the topical anti-inflammatory activity of some Central American plants,” Journal of Ethnopharmacology, vol. 81, no. 2, pp. 211–215, 2002.
View at: Publisher Site | Google Scholar
G. Yuan, M. L. Wahlqvist, G. He, M. Yang, and D. Li, “Natural products and anti-inflammatory activity,” Asia Pacific Journal of Clinical Nutrition, vol. 15, no. 2, pp. 143–152, 2006.
View at: Google Scholar
D. S. Fabricant and N. R. Farnsworth, “The value of plants used in traditional medicine for drug discovery,” Environmental Health Perspectives, vol. 109, no. 1, pp. 69–75, 2001.
View at: Publisher Site | Google Scholar
A. G. Durmowicz and K. R. Stenmak, “Mechanisms of structural remodeling in chronic pulmonary hypertension,” Pediatrics in Review, vol. 20, no. 11, pp. e91–e101, 1999.
View at: Google Scholar
M. C. Thomas, “Diuretics, ACE inhibitors and NSAIDs—the triple whammy,” Medical Journal of Australia, vol. 172, no. 4, pp. 184–185, 2000.
View at: Google Scholar
D. J. Newman and G. M. Cragg, “Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development,” Marine Drugs, vol. 12, no. 1, pp. 255–278, 2014.
View at: Publisher Site | Google Scholar
M. Sangeetha, K. Kousalya, R. Lavanya, C. Sowmya, D. Chamundeeswari, and C. Uma Maheswara Reddy, “In-vitro anti-inflammatory and anti-arthritic activity of leaves of Cleodendron inerme,” Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 2, no. 1, pp. 822–827, 2011.
View at: Google Scholar
I. F. Florentino, M. M. N. Vinícius, P. M. Galdino et al., “Evaluation of analgesic and anti-inflammatory activities of Hydrocotyle umbellata L., Araliaceae (acariçoba) in mice,” Anais da Academia Brasileira de Ciências, vol. 85, no. 3, pp. 987–997, 2013.
View at: Publisher Site | Google Scholar
S. Kumar, B. S. Bajwa, S. Kuldeep, and A. N. Kalia, “Anti-inflammatory activity of herbal plants: a review,” International Journal of Advances in Pharmacy, Biology and Chemistry, vol. 2, no. 2, pp. 272–281, 2013.
View at: Google Scholar
S. S. R. Bennet, P. C. Gupta, and R. V. Rao, Venerated Plants, ICFRE, Dehradun, India, 1992.
K. Ravi Kumar, D. K. Ved, R. Vijaya Sankar, and P. S. Udayan, 100 Red Listed Medicinal Plants of Conservation Concern in Southern India, Foundation for Revitalization of Local Health Traditions, Bangalore, India, 2000.
P. K. Warrier, V. P. K. Nambiar, and C. Ramamkutty, Indian Medicinal Plants, vol. 4, Orient Longman, Chennai, India, 1995.
M. Sawmliana, The Book of Mizoram Plants, Lois Bet, Chandmari, India, 1st edition, 2003.
National Innovation foundation-India, Department of Science and Technology, Ministry of India, http://nif.org.in/?q=medicinalproperties.
A. V. Raghu, S. George, V. Renju Krishna, and K. K. Sindhu, “Bioactive properties of phenolics present in Oroxylum indicum—a review,” Journal of Pharmacognosy and Phytochemistry, vol. 2, no. 3, pp. 23–27, 2013.
View at: Google Scholar
A. Ahad, A. A. Ganai, O. Sareer et al., “Therapeutic potential of Oroxylum indicum: a review,” Journal of Pharmaceutical Research & Opinion, vol. 2, no. 10, pp. 163–172, 2012.
View at: Google Scholar
M. Suffness and J. Douros, “Drugs of plant origin,” in Methods in Cancer Research, vol. 26, pp. 73–126, Academic Press, New York, NY, USA, 1979.
View at: Google Scholar
E. A. Asongalem, H. S. Foyet, J. Ngogang, G. N. Folefoc, T. Dimo, and P. Kamtchouing, “Analgesic and anti-inflammatory activities of Erigeron floribundus,” Journal of Ethnopharmacology, vol. 91, no. 2-3, pp. 301–308, 2004.
View at: Publisher Site | Google Scholar
H. Hosseinzadeh, M. Ramezani, and G.-A. Salmani, “Antinociceptive, anti-inflammatory and acute toxicity effects of Zataria multiflora Boiss extracts in mice and rats,” Journal of Ethnopharmacology, vol. 73, no. 3, pp. 379–385, 2000.
View at: Publisher Site | Google Scholar
S. Aydin, R. Beis, Y. Öztürk, K. Hüsnü, and C. Baser, “Nepetalactone: a new opioid analgesic from Nepeta caesarea Boiss,” Journal of Pharmacy and Pharmacology, vol. 50, no. 7, pp. 813–817, 1998.
View at: Publisher Site | Google Scholar
M. E. N. Nunez Guillen, J. A. da Silva Emim, C. Souccar, and A. J. Lapa, “Analgesic and antiinflammatory activities of the aqueous extract of Plantago major L.,” International Journal of Pharmacognosy, vol. 35, no. 2, pp. 99–104, 1997.
View at: Publisher Site | Google Scholar
R. S. Saxena, B. Gupta, K. K. Saxena, R. C. Singh, and D. M. Prasad, “Study of anti-inflammatory activity in the leaves of Nyctanthes arbor tristis Linn.—an Indian medicinal plant,” Journal of Ethnopharmacology, vol. 11, no. 3, pp. 319–330, 1984.
View at: Publisher Site | Google Scholar
C. N. Lumeng and A. R. Saltiel, “Inflammatory links between obesity and metabolic disease,” The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2111–2117, 2011.
View at: Publisher Site | Google Scholar
N. A. Punchard, C. J. Whelan, and I. Adcock, “The Journal of Inflammation,” Journal of Inflammation, vol. 1, article 1, pp. 1–4, 2004.
View at: Publisher Site | Google Scholar
A. Kuek, B. L. Hazleman, J. H. Gaston, and A. J. K. Östör, “Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximab,” Rheumatology, vol. 45, no. 11, pp. 1448–1449, 2006.
View at: Publisher Site | Google Scholar
S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, inflammation, and cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010.
View at: Publisher Site | Google Scholar
N. S. Jenny, “Inflammation in aging: cause, effect, or both?” Discovery Medicine, vol. 13, no. 73, pp. 451–460, 2012.
View at: Google Scholar
R. Hoque, A. Malik, F. Gorelick, and W. Mehal, “The sterile inflammatory response in acute pancreatitis,” Pancreas, vol. 41, no. 3, pp. 353–357, 2012.
View at: Publisher Site | Google Scholar
D. J. Marchant, J. H. Boyd, D. C. Lin, D. J. Granville, F. S. Garmaroudi, and B. M. McManus, “Inflammation in myocardial diseases,” Circulation Research, vol. 110, no. 1, pp. 126–144, 2012.
View at: Publisher Site | Google Scholar
T. Wyss-Coray and J. Rogers, “Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 1, Article ID a006346, 2012.
View at: Publisher Site | Google Scholar
A. Bartolini, A. Galli, C. Ghelardini et al., “Antinociception induced by systemic administration of local anaesthetics depends on a central cholinergic mechanism,” British Journal of Pharmacology, vol. 92, no. 4, pp. 711–721, 1987.
View at: Publisher Site | Google Scholar
C. A. Hiruma-Lima, J. S. Gracioso, E. J. B. Bighetti, L. Germonsén Robineou, and A. R. M. Souza Brito, “The juice of fresh leaves of Boerhaavia diffusa L. (Nyctaginaceae) markedly reduces pain in mice,” Journal of Ethnopharmacology, vol. 71, no. 1-2, pp. 267–274, 2000.
View at: Publisher Site | Google Scholar
U. A. Shinde, A. S. Phadke, A. M. Nair, A. A. Mungantiwar, V. J. Dikshit, and M. N. Saraf, “Studies on the anti-inflammatory and analgesic activity of Cedrus deodara (Roxb.) Loud. wood oil,” Journal of Ethnopharmacology, vol. 65, no. 1, pp. 21–27, 1999.
View at: Publisher Site | Google Scholar
B. V. Owoyele, S. B. Olaleye, J. M. Oke, and R. A. Elegbe, “Anti-inflammatory and analgesic activities of leaf extracts of Landolphia Owariensis,” African Journal of Biomedical Research, vol. 4, no. 3, pp. 131–133, 2010.
View at: Publisher Site | Google Scholar
K. Morteza-Semnani, M. Saeedi, and M. Hamidian, “Anti-inflammatory and analgesic activity of the topical preparation of Glaucium grandiflorum,” Fitoterapia, vol. 75, no. 2, pp. 123–129, 2004.
View at: Publisher Site | Google Scholar
A. Sharma, S. Bhatia, M. D. Kharya et al., “Anti-inflammatory and analgesic activity of different fractions of Boswellia serrata,” International Journal of Phytomedicine, vol. 2, no. 1, pp. 94–99, 2010.
View at: Publisher Site | Google Scholar
W. A. Mulla, S. D. More, S. B. Jamge, A. M. Pawar, M. S. Kazi, and M. R. Varde, “Evaluation of antiinflammatory and analgesic activities of ethanolic extract of roots Adhatoda vasica Linn,” International Journal of PharmTech Research, vol. 2, no. 2, pp. 1364–1368, 2010.
View at: Google Scholar
T. Afsar, M. R. Khan, S. Razak, S. Ullah, and B. Mirza, “Antipyretic, anti-inflammatory and analgesic activity of Acacia hydaspica R. Parker and its phytochemical analysis,” BMC Complementary and Alternative Medicine, vol. 15, article 136, 2015.
View at: Publisher Site | Google Scholar
D. Luttinger, “Determination of antinociceptive efficacy of drugs in mice using different water temperatures in a tail-immersion test,” Journal of Pharmacological Methods, vol. 13, no. 4, pp. 351–357, 1985.
View at: Publisher Site | Google Scholar
L. A. Dykstra, D. E. Gmerek, G. Winger, and J. H. Woods, “Kappa opioids in rhesus monkeys. Diuresis, sedation, analgesia and discriminative stimulus effects,” Journal of Pharmacology and Experimental Therapeutics, vol. 242, no. 2, pp. 413–420, 1987.
View at: Google Scholar
P. A. Janssen, C. J. Niemegeers, and J. G. Dony, “The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawl reflex in rats,” Arzneimittel-Forschung, vol. 13, pp. 502–507, 1963.
View at: Google Scholar
J. C. Zanini Jr., Y. S. Medeiros, A. B. Cruz, R. R. A. Yunes, and J. B. Calixto, “Action of compounds from Mandevilla velutina on croton oil-induced ear oedema in mice. A comparative study with steroidal and nonsteroidal antiinflammatory drugs,” Phytotherapy Research, vol. 6, no. 1, pp. 1–5, 1992.
View at: Publisher Site | Google Scholar
Y. F. Wang, S. H. Shao, P. Xu, X. Q. Yang, and L. S. Qian, “Catechin-enriched green tea extract as a safe and effective agent for antimicrobial and anti-inflammatory treatment,” African Journal of Pharmacy and Pharmacology, vol. 5, no. 12, pp. 1452–1461, 2011.
View at: Publisher Site | Google Scholar
M. Shibata, T. Ohkubo, H. Takahashi, and R. Inoki, “Modified formalin test: characteristic biphasic pain response,” Pain, vol. 38, no. 3, pp. 347–352, 1989.
View at: Publisher Site | Google Scholar
D. Le Bars, M. Gozariu, and S. W. Cadden, “Animal models of nociception,” Pharmacological Reviews, vol. 53, no. 4, pp. 597–652, 2001.
View at: Google Scholar
Y. Bhagyasri, V. Lavakumar, M. S. Divya Sree, and C. K. Ashok Kumar, “An overview on anti-inflammatory activity of Indian herbal plants,” International Journal of Research in Pharmaceutical and Nano Sciences, vol. 4, no. 1, pp. 1–9, 2015.
View at: Google Scholar
J. E. Chrubasik, B. D. Roufogalis, and S. Chrabasik, “Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain,” Phytotherapy Research, vol. 21, no. 7, pp. 675–683, 2007.
View at: Publisher Site | Google Scholar
J. Zhang, Y. Li, S.-S. Chen et al., “Systems pharmacology dissection of the anti-inflammatory mechanism for the medicinal herb Folium eriobotryae,” International Journal of Molecular Sciences, vol. 16, no. 2, pp. 2913–2941, 2015.
View at: Publisher Site | Google Scholar
K. Lalrinzuali, M. Vabeiryureilai, G. C. Jagetia, and P. C. Lalawmpuii, “Free radical scavenging and antioxidant potential of different extracts of Oroxylum indicum in vitro,” Advances in Biomedicine and Pharmacy, vol. 2, no. 3, pp. 120–130, 2015.
View at: Publisher Site | Google Scholar
K. L. A. Souza, E. Gurgul-Convey, M. Elsner, and S. Lenzen, “Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells,” Journal of Endocrinology, vol. 197, no. 1, pp. 139–150, 2008.
View at: Publisher Site | Google Scholar
B. Hoesel and J. A. Schmid, “The complexity of NF-κB signaling in inflammation and cancer,” Molecular Cancer, vol. 12, no. 1, article 86, 2013.
View at: Publisher Site | Google Scholar
D. C. Knight and J. A. Eden, “A review of the clinical effects of phytoestrogens,” Obstetrics & Gynecology, vol. 87, no. 5, part 2, pp. 897–904, 1996.
View at: Google Scholar
Y. Yao, L. Chen, J. Xiao et al., “Chrysin protects against focal cerebral ischemia/reperfusion injury in mice through attenuation of oxidative stress and inflammation,” International Journal of Molecular Sciences, vol. 15, no. 11, pp. 20913–20926, 2014.
View at: Publisher Site | Google Scholar
J. Clàiria, “Cyclooxygenase-2 biology,” Current Pharmaceutical Design, vol. 9, no. 27, pp. 2177–2190, 2003.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2016 K. Lalrinzuali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

5945

Downloads

3710

Citations